Back to Companies
ACTUATE THERAPEUTICS, INC.
ACTUNasdaqCIK: 0001652935
ACTUATE THERAPEUTICS, INC. (ACTU) shows 12 recent insider filings from 8 insiders, with 1 buying and 1 selling. With $50.0K in purchases and $1.6M in sales, the recent tape is heavily weighted toward selling (net sales of $1.6M). THOMSON TODD S is the most active by dollar volume, and the single largest transaction was $1.6M by THOMSON TODD S. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$7.1M
Purchases
$50.0K
Sales
$1.6M
Unique Insiders
8
Recent Insider Trades
12 loaded
| Oct 30 | ACTU ACTUATE THERAPEUTICS, INC. | BIOS Fund III, LP | Director, 10% Owner | Award | $1.6M |
| Oct 29 | ACTU ACTUATE THERAPEUTICS, INC. | SCHMITT DANIEL M | President, CEO and Director, Director | Buy | $50.0K |
| Nov 2 | ACTU ACTUATE THERAPEUTICS, INC. | THOMSON TODD S | Insider | Award | $372.7K |
| Oct 30 | ACTU ACTUATE THERAPEUTICS, INC. | BIOS Fund I, LP | Director, 10% Owner | Award | $1.6M |
| Aug 14 | ACTU ACTUATE THERAPEUTICS, INC. | SCHMITT DANIEL M | President, CEO and Director, Director | Exercise | $121.7K |
| May 22 | ACTU ACTUATE THERAPEUTICS, INC. | Sawhney Roger | Director | Award | $36.3K |
| May 22 | ACTU ACTUATE THERAPEUTICS, INC. | Keyes Jason A | Director | Award | $36.3K |
| Apr 1 | ACTU ACTUATE THERAPEUTICS, INC. | SCHMITT DANIEL M | President, CEO and Director, Director | Award | $590.1K |
| Apr 1 | ACTU ACTUATE THERAPEUTICS, INC. | LYTLE PAUL J | Chief Financial Officer | Award | $261.4K |
| Apr 1 | ACTU ACTUATE THERAPEUTICS, INC. | Mazar Andrew Paul | Chief Operating Officer | Award | $261.4K |
| Feb 13 | ACTU ACTUATE THERAPEUTICS, INC. | SCHMITT DANIEL M | President, CEO and Director, Director | Exercise | $527.7K |
| Jan 7 | ACTU ACTUATE THERAPEUTICS, INC. | THOMSON TODD S | Insider | Sell | $1.6M |
12 filings